Manipal Health Enterprises shares begin trading on the National Stock Exchange and Bombay Stock Exchange on Wednesday, August 5, marking the public debut of the Indian healthcare operator.
The listing follows a highly successful initial public offering that closed on July 31, with the book build issue subscribed 4.92 times overall, signaling robust investor appetite for the company’s equity.
Grey market premiums (GMP) are currently pricing the shares for a 33% gain over the issue price, suggesting a significant listing pop.
Grey market premiums (GMP) are currently pricing the shares for a 33% gain over the issue price, suggesting a significant listing pop.
This pre-market indicator reflects strong demand from both retail and institutional investors during the subscription window, which ran from July 29 to July 31.
The premium implies that market participants expect the stock to open well above its issue price, potentially rewarding early subscribers.
The IPO comprised a fresh issue of 13.56 million shares, aimed at raising capital for the company’s expansion plans.